Home LiteratureArticle Details
PMID: 16261613 Published · ppublish English Case Reports Comparative Study Journal Article Research Support, N.I.H., Extramural

Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation.

Pediatric blood & cancer ·Vol. 47 ·No. 3 ·2006-09-00 ·Pages 279-84

Janson K, Nedzi LA, David O, Schorin M, Walsh JW, Bhattacharjee M, Pridjian G, Tan L, Judkins AR, Biegel JA

Abstract

Germline mutations of the INI1 gene predispose children to the development of rhabdoid tumors. Reports of familial cases, however, are extremely rare. We have identified a three-generation family in which two half-brothers were diagnosed with central nervous system atypical teratoid/rhabdoid tumors (AT/RT). The two boys, diagnosed at 2 months and 17 months of age, had a germline insertion mutation in exon 4 of the INI1 gene that was inherited from their healthy mother. A maternal uncle died in childhood from a brain tumor and a malignant rhabdoid tumor of the kidney, and presumably carried the same germline mutation. As the mother and uncle had different fathers, the grandmother is also an obligate carrier of the mutation. The identification of two unaffected carriers in a family segregating a germline mutation and rhabdoid tumor supports the hypothesis that there may be variable risks of development of rhabdoid tumor in the context of a germline mutation. There may be a developmental window in which most rhabdoid tumors occur. This family highlights the importance of mutation analysis in all patients with a suspected rhabdoid tumor.

MeSH Terms
Antineoplastic Combined Chemotherapy Protocols/therapeutic use Chromosomal Proteins, Non-Histone/genetics DNA Mutational Analysis/methods DNA-Binding Proteins/genetics Genetic Predisposition to Disease Germ-Line Mutation Humans Immunohistochemistry Infant Magnetic Resonance Imaging Male Pedigree Rhabdoid Tumor/drug therapy,genetics,pathology Risk Factors SMARCB1 Protein Sensitivity and Specificity Teratoma/drug therapy,genetics,pathology Transcription Factors/genetics Treatment Outcome
Chemicals
Chromosomal Proteins, Non-Histone DNA-Binding Proteins SMARCB1 Protein SMARCB1 protein, human Transcription Factors
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Janson Kristin
Department of Radiation Oncology, Tulane University, New Orleans, Los Angeles, USA.
Nedzi Lucien A
David Odile
Schorin Marshall
Walsh John W
Bhattacharjee Meena
Pridjian Gabriella
Tan Lu
Judkins Alexander R
Biegel Jaclyn A
Article Info
Journal
Pediatric blood & cancer
Abbr.
Pediatr Blood Cancer
ISSN
1545-5009
Published
2006-09-00
Pages
279-84
Language
English
Region
United States
NLM ID
101186624
Subset
IM
Grants
NCI NIH HHS · CA46274 · United States
NCI NIH HHS · CA98543 · United States
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com